EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   2.7.7.49 | Neoplasms |
28223935 |
|
unassigned |
0 |
| 2.7.7.49 | Acquired Immunodeficiency Syndrome |
10962282 |
'Infectious web'. |
unassigned |
0 |
| 2.7.7.49 | Neoplasms |
10962282 |
'Infectious web'. |
unassigned |
0 |
| 2.7.7.49 | Acquired Immunodeficiency Syndrome |
25728026 |
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 2.7.7.49 | Neoplasms |
23055531 |
1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 2.7.7.49 | Ovarian Neoplasms |
23055531 |
1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 2.7.7.49 | Neoplasms |
25965776 |
1,3,4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents. |
causal interaction
unassigned |
1
0 |
| 2.7.7.49 | Neoplasms |
9703471 |
1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 2.7.7.49 | Breast Neoplasms |
32486108 |
1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 2.7.7.49 | Glioblastoma |
32486108 |
1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
